NB-UVB phototherapy is standard of care (SOC) in a number of immune-dysregulated diseases. Guidelines of care for atopic dermatitis. 3 0 obj J Invest Dermatol. Cochrane Database Syst Rev. Storbeck K, Holzle E, Schurer N, et al. Alopecia Mucinosa. Patients in treatment (n = 15) and placebo (n = 15) arms had similar demographics. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Web(9690096999) special dermatological procedures (9700197799) physical medicine and rehabilitation (9780297804) medical nutrition therapy (9781097814) acupuncture (9892598929) osteopathic manipulative treatment (9894098943) chiropractic manipulative treatment (9896098962) education and training for patient self-management 2003;4(2):97-105. Moreover, these investigators stated that the drawbacks of this trial were that it was a retrospective study with a small sample size (n = 10 in each of the 2 treatment groups) and without a control group. Photochemotherapy treatment of pruritus associated with polycythemia vera. 2010;85(5):621-624. Narrow-band ultraviolet B radiation: A review of the current literature. UpToDate [online serial]. The statistical power for a Fisher's exact test with 15 patients per group given the rates of 28day mortality observed in this pilot was 14.1 %. For each patient, total numbers of PUVA or NB-UVB exposures, the cumulative UV dose (J/cm2 ), serum tryptase profile, and pruritus, before and after treatment, according to the VAS were considered. Erythema annulare centrifugum. Management and treatment with phototherapy and systemic agents. REIMBURSEMENT INFORMATION: Refer to section entitled POSITION STATEMENT. Tan AWH, Giam YC. %PDF-1.4 The Centers for Medicare 038 Medicaid Services CMS issued April 10 the Inpatient Prospective Payment SystemLongTerm Care Hospital IPPSLTCH proposed rule for fiscal year FY 2024. This indicated that cure may have been achieved in a minority of patients. Ghoreschi K, Thomas P, Penovici M, et al. Zheng Y, Jia J, Tian Q, et al. List of CPT/HCPCS Codes. Furthermore, an UpToDate review on Erythema annulare centrifugum (Haeberle, 2021) does not mention NB-UVB as a management / therapeutic option. Samson Yashar S, Gielczyk R, Scherschun L, Lim HW. This power calculation will be used to refine the biostatistical considerations for the planned, larger clinical trial. Castells MC, Akin C. Cutaneous mastocytosis: Treatment, monitoring, and prognosis. Although 96920 for excimer is technically only for psoriasis, some payers will let you use it for other diagnoses since there is no other excimer code. Wolff D, Steiner B, Hildebrandt G, et al. 2014;27(4):233-235. 1995;133(6):914-918. Available at:http://emedicine.medscape.com/article/1123031-treatment. UpToDate [online serial]. 04/17/2023 Riemann H, High WA. The authors concluded that LyP is a type of low-level malignant lymphoma and is easily misdiagnosed as pityriasis lichenoides et varioliformis acuta and other diseases. Marsland AM, Chalmers RJG, Hollis S, et al. Elmets CA. View the PDF. Rep Pract Oncol Radiother. WebSUNY Downstate Health Sciences University, School of Health Professions Medical Billing and Coding program is a certificate program designed to assist individuals entering the field of medical billing and coding, or preparing for certification. %PDF-1.4 1):215-219. 2002;127(2):156-159. The median VAS score at the beginning of the treatment was 86.6 (SD = 6.64), whereas it decreased to 6.66 (SD = 3.75) after 3 months of therapy. Waltham, MA: UpToDate; reviewed December 2022. TB*\iB1M;n dDj\F%rP>z9w@)sV8+Sv`71i`[=e1hb.$uwu$?v>E@ [:7PT-4Lof/K)v;FJ9'Rt+EAtsL^-hkWiI%wcrPW>a 6368? Narrow-band UVB phototherapy for the following indications: Cutaneous mastocytosis (after conventional therapies have failed); Kyrle disease (perforating dermatosis) that is refractory to topical or intralesional therapy; Photodermatoses (e.g., actinic dermatitis and solar urticaria; Prurigo nodularis that is refractory to topical or intralesional corticosteroids; Uremic pruritusthat is refractory to emollients, topical analgesics and oral antihistamines or gabapentin. Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U. 2016;30(9):1465-1479. Unfortunately, the lesions relapsed, whenever phototherapy was discontinued. Dermatol Ther. PROGRAM EXCEPTIONS: Federal Employee Program (FEP): Follow FEP guidelines. 1996;35(12):890-891. Claes C, Kulp W, Greiner W, et al. Subscribe to Anesthesia Coder today. The AMA released a CPT code for use in non-facility settings for the expense related to supplies, equipment and staff time and activities for visits performed during the PHE due to respiratory-transmitted infectious disease, effective Sept 8, 2020 Some commercial payers are recognizing the paying a small amount for this code. 2009;338:b1542. Photodermatol Photoimmunol Photomed. Sun protection - Sun protection is first-line therapy for patients with PMLE and includes sun avoidance, sun protective clothing, and sunscreens. Aetna Inc. and its subsidiary companies are not responsible or liable for the content, accuracy, or privacy practices of linked sites, or for products or services described on these sites. Primary outcomes were safety and effectiveness, defined as persistent or painful erythema and 28-day mortality. View any code changes for 2023 as well as historical information on code creation and revision. Moreover, the authors concluded that controlled studies are needed to examine the full potential of conventional phototherapy in the management of MF. Fesq and colleagues (2003) stated that management of PLE should focus on basic preventative measures and additional therapeutic approaches, depending on the clinical condition. 2010;22(1):1-8. <> Menage HD, Norris PG, Hawk JL, Graves MW. In: BMJ Clinical Evidence. Waltham, MA: UpToDate; reviewed December 2017. Narrow-band UVB phototherapy for management of oral chronic graft-versus-host disease. 2000;142(1):39-43. Moreover, these researchers stated that further longitudinal studies are needed to examine prognostic differences between CD4(+) and CD8(+) LyP and their biological significance. Riboflavin and ultraviolet light a therapy as an adjuvant treatment for medically refractive acanthamoeba keratitis: Report of 3 cases. Suh KS, Kang JS, Baek JW, et al. 1993;28(2 Pt 1):227-231. UpToDate [online serial]. NB-UVB phototherapy in hospitalized COVID-19 patients was safe. General Haematology Task Force, British Committee for Standards in Haematology. However, there is no specific CPT code for light therapy for vitiligo. 1994;31(5):775-790. J Am Acad Dermatol. The authors concluded that these findings indicated that home phototherapy may be a therapeutic option for treatment of selected patients with early MF. 2004;140(12):1463-1466. A randomized comparison of narrow-band TL-01 phototherapy and PUVA photochemotherapy for psoriasis. The patient was in good health without lesions after 12 months of follow-up. Menter A, Korman NJ, Elmets CA, et al. Griffiths CE, Clark CM, Chalmers RJ, et al. Montero LC, Belinchn I, Toledo F, Betlloch I. Guidelines for the Diagnosis, Investigation and Management of Polycythaemia/Erythrocytosis. J Am Acad Dermatol. J Allergy Clin Immunol. Home ultraviolet light booths or ultraviolet lamps, as well as replacement bulbs sold by prescription only, for persons eligible for home UVB phototherapy. Gambichler T, Breuckmann F, Boms S, et al. % 2015;31(2):75-82. van Coevorden AM, Kamphof WG, van Sonderen E, et al. In a case report, Tan and Giam (2004) reported on the findings of a 44-year-old woman with recurrent crops of papules and nodules of lymphomatoid papulosis and who had early-stage mycosis fungoides. Ann Hematol. AmericanAcademy of Dermatology (AAD). 4 0 obj A complete remission of the cutaneous lesions and pruritus was documented in all patients after a median of 40.3 UV treatments and a median cumulative dose of 51.4 J/cm(2), with a lasting remission over a 6-month follow-up. The tapering schedule is non-standardized and differs by institution. 1999;40(6 Pt 1):995-997. We typically use clobetasol propionate 0.05 % ointment 2 or 3 times per day for 4 to 8 weeks. % American Academy of Dermatology Committee on Guidelines of Care. February 14, 2017. There are also contraindications for patients with significant hepatic impairment and for those taking warfarin or phenytoin. 2006;(1):CD001433. Psoralens and ultraviolet A light (PUVA) treatments for the following conditions after conventional therapies have failed: Cutaneous T-cell lymphoma (mycosis fungoides); Cutaneous manifestations of graft versus host disease; Eosinophilic folliculitis and other pruritic eruptions of HIV infection; Grover's disease (transient and persistent acantholytic dermatosis); Morphea (circumscribed scleroderma)and localized skin lesions associated with scleroderma; Severe refractory atopic dermatitis/eczema; Severe refractory pruritus of polycythemia vera; Severe urticaria pigmentosa (cutaneous mastocytosis); Severely disabling psoriasis (i.e., psoriasis involving 10 % or more of the body, or severe psoriasis involving the hands, feet, or scalp); Phototherapy with UVA medically necessary for the following indications: Scleredema that is functionally limiting or symptomatic. CD30, a helper T-cell marker specifically expressed in tumor cells was analyzed by immunohistochemical (IHC) staining and the result showed that CD30-negative or only scattered CD30-positive cells were present; thus, a diagnosis of type B LyP was made. Comparative study of systemic psoralen and ultraviolet A and narrowband ultraviolet B in treatment of chronic urticaria. Der-Petrossian M, Seeber A, Honigsmann H, Tanew A. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. UpToDate [online serial]. Type A LyP was identified in 12 patients, 1 patient had type B, and none had type C (type not determined in 1case). Waltham, MA: UpToDate; reviewed November 2019. Waltham, MA: UpToDate; reviewed December 2021. Cooper SM, Burge SM. N Engl J Med. Cochrane Database Syst Rev. 2006;31(2):235-238. UpToDate [online serial]. Lewis FM, Tatnall FM, Velangi SS, et al. Taylor CR, Hawk JL. The number of treatments needed to attain symptom relief was significantly lower in the PUVA group, but the mean exposure dose was significantly higher, if compared to the NB-UVB group. d)5"k{vN&/"vF*+'}> /bhE~Vrs'YV@?N?+7ZCWuQ.OnufG\W;W[1ouJ? 2012;26 Suppl 3:11-21. 1993;128(1):49-56. Serum tryptase levels showed a downward trend. Reynolds NJ, Franklin V, Gray JC, et al. Clin Exp Dermatol. UpToDate [online serial]. CPT Code 96900. Am Fam Physician. Helsinki, Finland: Duodecim Medical Publications Ltd.; June 18, 2004. Ziemer M. Lichenoid drug eruption (drug-induced lichen planus). Br J Dermatol. UpToDate [online serial]. Am J Hematol. Petersen et al (2018) stated that radiation induced morphea (RIM) is an increasingly common complication of radiation treatment for malignancy as early detection has made more patients eligible for non-surgical therapeutic options. The lesions of LyP responded to intermittent courses of oral methotrexate. (Note: This amount is what Medicare allows; other commercial carriers may pay a little Br J Dermatol. Search across Medicare Manuals, Transmittals, and more. Overview of cutaneous lupus erythematosus. Swerlick RA. In most studies, UV phototherapy (NB-UVB, broadband UVB, UVA1 or PUVA) was employed. It may be reported using the CPT 96999, but the CPT codes for 96900-96910 for light box might also be used. Decreased mortality was observed in treated patients; however, this was statistically non-significant. The 28-day mortality was 13.3 % in treatment versus 33.3 % in placebo arms (p = 0.39). 2017;70(5):638-655. Semin Cutan Med Surg. However, there are no randomized trials evaluating the relative efficacy of these phototherapy modalities in patients with early-stage MF NBUVB phototherapy is administered in a dermatology office 3 to 5 times per week with gradual incremental dose delivery. Hofer A, Cerroni L, Kerl H, Wolf P. Narrowband (311-nm) UVB therapy for small plaque parapsoriasis and early-stage mycosis fungoides. 2011;63(4):327-333. Available at: https://emedicine.medscape.com/article/1070090-overview. A systematic review of treatments for severe psoriasis. Diederen P, van Weelden H, Sanders C, et al. WebSUNY Downstate Health Sciences University, School of Health Professions Medical Billing and Coding program is a certificate program designed to assist individuals entering the Treatment was started using a UVB phototherapy handpiece (twice-weekly), with resolution of the lesions after 6 weeks of treatment. J Eur Acad Dermatol Venereol. ^.AtGT"$mXJ5>O 70Z~QMlZqk(g!a5t=&D&V;v085tu}*s~iQn,kd7X@hg:=ZyY{L.-tRwJ0#T4a@smysDX*>e hS}*=hn?=M.Z%Kn4I i~xNZw`+zM7iqMY-P'gQe%4u`=ZGYx_jZN# 86WDTI 57Qn-OmGhCQ= Hautarzt. The eruption was not responsive to the initial treatment of topical betamethasone dipropionate 0.1 % ointment and oral prednisolone. If they won't a Is CPT 96900 correct for billing Excimer Laser for Vitiligo? Clearance rates with the different modalities were hardly comparable between different studies, ranging approximately between 70 % and 100 %. The main drawbacks of this trial were that this was a single-case study; and the hypersensitive rash was caused by the ingestion of an Ecstasy tablet. Bohjanen K, Miller DD. In a review on Phototherapy of mycosis fungoides (Hodak and Pavlovsky, 2015), home phototherapy is not mentioned as therapeutic option. Brenner M, Herzinger T, Berking C, et al. Health Technol Assess. Association with hematologic neoplasia has been reported in 5 % to 20 % of all cases. An NCD defines coverage for a particular item (e.g., a brace or hearing aid) or service (e.g., therapy or screenings) nationwide. 2005;53(1):149-151. 2013;29(1):12-17. J Am Acad Dermatol. Managed cares perspective on treatment of psoriasis. View matching HCPCS Level II codes and their definitions. Ann Acad Med Singapore. 1999;41(5 Pt 1):728-732. Loading Waltham, MA: UpToDate; reviewed December 2017. Am J Clin Dermatol. Milstein HJ, Vonderheid EC, Van Scott EJ, Johnson WC. J Dermatolog Treat. 167. &" For FREE Trial. The perception of pruritus severity was examined using the visual analogue scale (VAS) before starting the treatment and at each control. After a complete response is achieved, the frequency of therapy is tapered very slowly during the maintenance period and then discontinued. Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. J Dtsch Dermatol Ges. Try entering any of this type of information provided in your denial letter. Am J Clin Dermatol. J Am Acad Dermatol. Try entering any of this type of information provided in your denial letter. 2005;115(3):541-547. Psoriasis and Reiter's syndrome. Section 3. They usually do not have too many restrictions on this code, since it only pays about $20. Pugashetti R, Lim HW, Koo J. Broadband UVB revisited: Is the narrowband UVB fad limiting our therapeutic options? Histopathologic findings include multinucleated giant cells For patients with symptomatic disease involving a limited skin area (e.g., the extremities), we suggest topical corticosteroids rather than oral corticosteroids (Grade 2C). Furthermore, an UpToDate review on Pityriasis lichenoides chronica (Musiek, 2022) states that Narrowband ultraviolet B (NBUVB), broadband ultraviolet B (UVB), and psoralen plus ultraviolet A (PUVA) are the primary phototherapeutic modalities used to treat these diseases. The blood test distributor agrees to pay 195000 to settle allegations that it violated the FCA. 2018. Waltham, MA: UpToDate; reviewed November 2013. NCCN Clinical Practice Guidelines in Oncology, Version 1.2022. Cyr PR. Phototherapy may be considered for temporary symptomatic relief in patients with diffuse cutaneous mastocytosis with extensive skin involvement refractory to medical management. Fidelis had gave us a same issue and now united healthcare. Lesions improved with treatment in most cases, and none of the cases was associated with hematologic malignancies. They usually do not have too many restrictions on this code, since it only pays about $20. Photodermatol Photoimmunol Photomed. After 4 weeks of treatment the skin lesions had cleared nearly completely without any side effects. The 2 patients exhibited symptoms with papulonodular lesions, the centers of which gradually underwent ulceration and necrosis. Psoriasis: Recommendations for UVB combination therapies. UpToDate [online serial]. Clin Exp Dermatol. 2011;66(5):453-457. history of ionizing radiation exposure; or, history or presence of melanoma or other skin cancer; or. 2005;52(4):660-670. Coding issues have been identified throughout all the molecular pathology coding subgroups, but these issues of billing multiple CPT codes for a specific test have been significant in the Tier 2 (81400 - 81408) and Not Otherwise Classified (81479 and 81599) codes. Mycosis fungoides was treated with oral psoralen and ultraviolet A phototherapy with good response. Furthermore, an UpToDate review on Vulvar lichen sclerosus (Cooper and Arnold, 2021) does not mention narrow-band ultraviolet B (NB-UVB) as a management / therapeutic option. Narrowband UVB treatment of progressive macular hypomelanosis. An Bras Dermatol. In order to avoid under-diagnosis and misdiagnosis, physicians should examine suspected patients by histopathological and IHC examination. Dermatology. The authors stated that the main drawbacks of this study were its retrospective design and its small sample size (n = 14 pediatric subjects). 4) Visit Medicare.gov or 2012;26(4):465-469. Dermatol Clin. To plug inpatient facility revenue drains, subscribe to DRG Coder today. The FTC proposes to ban noncompete clauses in employment contracts. Phototherapy for atopic eczema with narrow-band UVB. Cochrane Database Syst Rev. The efficacy and long-term safety of UVA1 therapy has not been evaluated and therefore should be used with caution in patients younger than 18 years. Honig B, Morison WL, Karp D. Photochemotherapy beyond psoriasis. Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. 2012;63(2):89-96. Am J Clin Dermatol. PUVA-bath photochemotherapy and isotretinoin in sclerodermatous graft-versus-host disease. J Am Acad Dermatol. Article revised and published on 12/09/2021 effective for dates of service on and after 12/12/2021. Wl|ury{4G0K(fWtWaFF~EEd 5RUVC!Wj%,x x}aLp5+`Q|5gvu0uSj K Oeol/vrcYU ogjG0ke5G^$)Kma]6 2010;137(1):21-31. in order to bill the 96910 can the patient apply (we use Vanicream) themselves or does the nurse have to do it? 2016;32(5-6):238-246. Cutaneous manifestations of amyloidosis. We generally use a super-potent topical corticosteroid (e.g., clobetasol propionate 0.05 %) ointment or cream twice daily for 2 to 4 weeks. 2000;42(2 Pt 1):208-213. A complete clinical and histologic remission of disease, lasting for a median duration in excess of 18 months, was achieved in 19 patients (61 %) with MF. Cochrane Database Syst Rev. UpToDate [online serial]. WebCODING/BILLING INFORMATION The inclusion or exclusion of a code in this section does not necessarily indicate coverage. The papules of LyP continued to appear but she remained free of lesions of mycosis fungoides 10 months following cessation of NB-UVB therapy. Hodak E, Pavlovsky L. Phototherapy of mycosis fungoides. Brazzelli et al (2012) stated that mastocytoses represent a heterogeneous group of stem cell disorders marked by an abnormal hyperplasia and accumulation of mast cells in one or more tissues, including bone marrow, gastro-intestinal (GI) tract, liver, spleen, lymph nodes and skin. Photodermatol Photoimmunol Photomed. Since then, she has had recurrence of mycosis fungoides following the cessation of phototherapy; but exhibited no evidence of systemic involvement. An evidence-based analysis on Ultraviolet phototherapy management of moderate-to-severe plaque psoriasis (Medical Advisory Secretariat, 2009) noted that there are a range of contraindications for UVB phototherapy and for PUVA. 2012;53(2):136-138. 2011;27(3):162-163. Waltham, MA: UpToDate; reviewed December 2015. Participants were treated daily with escalating doses on 27 % of their body surface area for up to 8 consecutive days. An UpToDate review on UVB therapy (broadband and narrowband) (Honigsmann, 2019) lists lupus erythematosus and xeroderma pigmentosum as absolute contraindications as well as history of photosensitivity diseases (e.g., chronic actinic dermatitis, solar urticaria), history of melanoma, history of nonmelanoma skin cancer, history of treatment with arsenic or ionizing radiation because of the increased risk for skin cancer, and immunosuppression for organ transplant patients as relative contraindications. Health Technol Assess. RIM is often mistaken for radiation dermatitis or cellulitis. Oral psoralen photochemotherapy (PUVA) for pruritus associated with polycythemia vera and myelofibrosis [letter]. Kobrin SM. WebFor CPT Code 96900. J Am Acad Dermatol. 2nd ed. Pilot phase results of a prospective, randomized controlled trial of narrowband ultraviolet B phototherapy in hospitalized COVID-19 patients. UpToDate [online serial]. 4) Visit Medicare.gov or Olsen EA, Hodak E, Anderson T, et al. There was a relapse after 9 months with a good response after 6 more sessions of treatment. <> Cochrane Database Syst Rev. A complete clinical and histologic response to home phototherapy occurred in 23 patients (74 %) with a maximum duration of the response from 5 months to more than 15 years (median of 51 months). 2003;12(5 Suppl):14-17. This Clinical Policy Bulletin may be updated and therefore is subject to change. Cochrane Database Syst Rev. 2018;178(4):839-853. A total of 24 patients with CU were included and divided into 2 groups: CPB 0577 - Laser Treatment for Psoriasis and Other Selected Skin Conditions. UpToDate [online serial]. For additional language assistance: Photochemotherapy; psoralens and ultraviolet A (PUVA), Photochemotherapy (Goeckerman and/or PUVA) for severe photoresponsive dermatoses requiring at least 4-8 hours of care under direct supervision of the physician (includes applications of medication and dressings), Human immunodeficiency virus [HIV] disease, Mycosis fungoides and cutaneous T-cell lymphoma, Primary cutaneous CD30-positive T-cell proliferations, Transient acantholytic dermatosis [Grover], Psoriasis [severe disabling, involving 10% or more of body or severe psoriasis involving the hands, feet or scalp], Other specified acute skin changes due to ultraviolet radiation, Mastocytosis [Urticaria pigmentosa] [severe], Other complications of bone marrow transplant [skin conditions], Other histiocytosis syndromes. Dummer R, Ivanova K, Scheidegger EP, Burg G. Clinical and therapeutic aspects of polymorphous light eruption. Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Evidence-Based Medicine [CD-ROM]. Br J Dermatol. The authors concluded that among their pediatric patients, these investigators noted a predominance of CD8(+) LyP, which did not appear to have an aggressive course. London, UK: BMJ Publishing Group; August 2007. Rhinophototherapy: A new therapeutic tool for the management of allergic rhinitis. Narrow-band ultraviolet B phototherapy versus broad-band ultraviolet B or psoralen-ultraviolet A photochemotherapy for psoriasis. An UpToDate review on UVA1 phototherapy (Krutmann and Morita, 2019) states that Ultraviolet A1 (UVA1) phototherapy is contraindicated in patients with xeroderma pigmentosum, porphyria, melanoma and nonmelanoma skin cancer, and in patients on long-term immunosuppressive therapy (e.g., after organ transplantation). 96920 - CPT Code in category: Laser treatment for inflammatory skin disease (psoriasis) CPT Code information is available to subscribers and includes the CPT code number, short description, long description, guidelines and more. 2011;30(4):190-198. Dermatol Clin. Raler F, Lukacs J, Elsner P. Treatment of eosinophilic cellulitis (Wells syndrome) - a systematic review. Lancet. Most insurance carriers cover 96900. k#HFTSdqw Beattie PE, Dawe RS, Ibbotson SH, Ferguson J. UVA1 phototherapy for treatment of necrobiosis lipoidica. Accessed January 16, 2018. Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: An effective preventative treatment for the photodermatoses. Rongioletti F. Localized lichen myxedematosus. Reuter J, Braun-Falco M, Termeer C, Bruckner-Tuderman L. Erythema annulare centrifugum darier. The lesions typically present within 1 year of radiation therapy and extend beyond the radiated field. It is imperative to diagnose RIM early as it carries significant morbidity and permanent deformity if left untreated. Reuter et al (2007) noted that erythema annulare centrifugum is an acute dermatosis of unclear etiology, which presents with annular erythematous lesions with marginal scale. J Am Acad Dermatol. Treatment options for localized scleroderma. 2014;8(6):1927-1933. [/QUOTE] Tan E, Lim D, Rademaker M. Narrowband UVB phototherapy in children: A New Zealand experience. These researchers presented follow-up data of the original 31 patients, covering an interval of up to 15 years. Lymphomatoid papulosis. Australas J Dermatol. These investigators carried out a systematic review according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for studies examining PL treatment including 3 or more subjects and published in English between January 1, 1970 and April 15, 2019. Treating providers are solely responsible for medical advice and treatment of members. 2015;33(4):697-702. Phototherapy and photochemotherapy of sclerosing skin diseases. Eight years after the initial onset of these lesions she developed cutaneous T-cell lymphoma (mycosis fungoides). Delrosso G, Bornacina C, Farinelli P, et al. UpToDate [online serial]. 1999;(2):CD001168. 2004;50(3):391-404. Furthermore, an UpToDate review on Lymphomatoid papulosis (Kadin, 2022) states that For patients with extensive or symptomatic disease, scarring, or cosmetic concerns, we suggest low-dose methotrexate as the initial therapy (Grade 2C) For patients for whom methotrexate is contraindicated and for patients with LyP that does not respond to methotrexate, we suggest psoralen and ultraviolet A (PUVA) therapy (Grade 2C). Lymphomatoid papulosis misdiagnosed as pityriasis lichenoides et varioliformis acuta: Two case reports and a literature review.